Upregulation of the p53R2 ribonucleotide reductase subunit by nitric oxide

Nitric Oxide - Biology and Chemistry

Volumn 19, Issue 2, 2008, Pages 84-94

  Guittet, Olivier ^a   Tebbi, Ali ^a   Cottet, Marie Hélène ^a   Vésin, Françoise ^a   Lepoivre, Michel ^a  

^a CNRS   (France)

Author keywords

DNA repair; Gene regulation; Nitric oxide; p53; Ribonucleotide reductase

Indexed keywords

MESSENGER RNA; MITOCHONDRIAL DNA; NITRIC OXIDE; RIBONUCLEOTIDE REDUCTASE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; ENZYME REGULATION; ENZYME SUBUNIT; GENE INDUCTION; GENOTOXICITY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; UPREGULATION;

ANIMALS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELLS, CULTURED; COCULTURE TECHNIQUES; DNA DAMAGE; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MACROPHAGES; MICE; NITRIC OXIDE; NUCLEAR PROTEINS; PROTECTIVE AGENTS; PROTEIN SUBUNITS; RIBONUCLEOTIDE REDUCTASES; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 47049119067     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.niox.2008.04.011     Document Type: Article

References (36)

1. Tanaka H., Arakawa H., Yamaguchi T., Shiraishi K., Fukuda S., Matsui K., Takei Y., and Nakamura Y. A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage. Nature 404 (2000) 42-49
2. Guittet O., Håkansson P., Voevodskaya N., Fridd S., Gräslund A., Arakawa H., Nakamura Y., and Thelander L. Mammalian p53R2 protein forms an active ribonucleotide reductase in vitro with the R1 protein, which is expressed both in resting cells in response to DNA damage and in proliferating cells. J. Biol. Chem. 276 (2001) 40647-40651
3. Chabes A.L., Pfleger C.M., Kirschner M.W., and Thelander L. Mouse ribonucleotide reductase R2 protein: a new target for anaphase-promoting complex-Cdh1-mediated proteolysis. Proc. Natl. Acad. Sci. USA 100 (2003) 3925-3929
4. Filatov D., Björklund S., Johansson E., and Thelander L. Induction of the mouse ribonucleotide reductase R1 and R2 genes in response to DNA damage by UV light. J. Biol. Chem. 271 (1996) 23698-23704
5. Zhou B.S., Liu X.Y., Mo X.L., Xue L.J., Darwish D., Qiu W.H., Shih J., Hwu E.B., Luh F., and Yen Y. The human ribonucleotide reductase subunit hRRM2 complements p53R2 in response to UV-induced DNA repair in cells with mutant p53. Cancer Res. 63 (2003) 6583-6594
6. Tsai M.H., Chen X., Chandramouli G.V., Chen Y., Yan H., Zhao S., Keng P., Liber H.L., Coleman C.N., Mitchell J.B., and Chuang E.Y. Transcriptional responses to ionizing radiation reveal that p53R2 protects against radiation-induced mutagenesis in human lymphoblastoid cells. Oncogene 25 (2006) 622-632
7. Hofseth L.J., Hussain S.P., and Harris C.C. p53: 25 years after its discovery. TIPS 25 (2004) 177-181
8. Müller M., Schleithoff E.S., Stremmel W., Melino G., Krammer P.H., and Schilling T. One two three--p53 p63 p73 and chemosensitivity. Drug Resist. Updat. 9 (2006) 288-306
9. Murray-Zmijewski F., Lane D.P., and Bourdon J.C. p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress. Cell Death Differ. 13 (2006) 962-972
10. Harms K., Nozell S., and Chen X. The common and distinct target genes of the p53 family transcription factors. Cell. Mol. Life Sci. 61 (2004) 822-842
11. Kimura T., Takeda S., Sagiya Y., Gotoh M., Nakamura Y., and Arakawa H. Impaired function of p53R2 in Rrm2b-null mice causes severe renal failure through attenuation of dNTP pools. Nat. Genet. 34 (2003) 440-445
12. Byun D.S., Chae K.S., Ryu B.K., Lee M.G., and Chi S.G. Expression and mutation analyses of P53R2 a newly identified p53 target for DNA repair in human gastric carcinoma. Int. J. Cancer 98 (2002) 718-723
13. Nakano K., Balint E., Ashcroft M., and Vousden K.H. A ribonucleotide reductase gene is a transcriptional target of p53 and p73. Oncogene 19 (2000) 4283-4289
14. Vayssade M., Haddada H., Faridoni Laurens L., Tourpin S., Valent A., Benard J., and Ahomadegbe J.C. p73 functionally replaces p53 in Adriamycin-treated p53-deficient breast cancer cells. Int. J. Cancer 116 (2005) 860-869
15. Yanamoto S., Iwamoto T., Kawasaki G., Yoshitomi I., Baba N., and Mizuno A. Silencing of the p53R2 gene by RNA interference inhibits growth and enhances 5-fluorouracil sensitivity of oral cancer cells. Cancer Lett. 223 (2005) 67-76
16. Pontarin G., Ferraro P., Håkansson P., Thelander L., Reichard P., and Bianchi V. p53R2-dependent ribonucleotide reduction provides deoxyribonucleotides in quiescent human fibroblasts in the absence of induced DNA damage. J. Biol. Chem. 282 (2007) 16820-16828
17. Bourdon A., Minai L., Serre V., Jais J.P., Sarzi E., Aubert S., Chretien D., de Lonlay P., Paquis-Flucklinger V., Arakawa H., Nakamura Y., Munnich A., and Rötig A. Mutation of RRM2B encoding p53-controlled ribonucleotide reductase (p53R2) causes severe mitochondrial DNA depletion. Nat. Genet. 39 (2007) 776-780
18. Bogdan C. Nitric oxide and the immune response. Nat. Immunol. 2 (2001) 907-916
19. Ohshima H. Genetic and epigenetic damage induced by reactive nitrogen species: implications in carcinogenesis. Toxicol. Lett. 140-141 (2003) 99-104
20. Dedon P.C., and Tannenbaum S.R. Reactive nitrogen species in the chemical biology of inflammation. Arch. Biochem. Biophys. 423 (2004) 12-22
21. Akaike T., Fujii S., Kato A., Yoshitake J., Miyamoto Y., Sawa T., Okamoto S., Suga M., Asakawa M., Nagai Y., and Maeda H. Viral mutation accelerated by nitric oxide production during infection in vivo. FASEB J. 14 (2000) 1447-1454
22. Ding X.H., Hiraku Y., Ma N., Kato T., Saito K., Nagahama M., Semba R., Kuribayashi K., and Kawanishi S. Inducible nitric oxide synthase-dependent DNA damage in mouse model of inflammatory bowel disease. Cancer Sci. 96 (2005) 157-163
23. Hofseth L.J., Saito S., Hussain S.P., Espey M.G., Miranda K.M., Araki Y., Jhappan C., Higashimoto Y., He P.J., Linke S.P., Quezado M.M., Zurer I., Rotter V., Wink D.A., Appella E., and Harris C.C. Nitric oxide-induced cellular stress and p53 activation in chronic inflammation. Proc. Natl. Acad. Sci. USA 100 (2003) 143-148
24. Schneiderhan N., Budde A., Zhang Y.P., and Brüne B. Nitric oxide induces phosphorylation of p53 and impairs nuclear export. Oncogene 22 (2003) 2857-2868
25. Kim S.J., Hwang S.G., Shin D.Y., Kang S.S., and Chun J.S. p38 kinase regulates nitric oxide-induced apoptosis of articular chondrocytes by accumulating p53 via NF kappa B-dependent transcription and stabilization by serine 15 phosphorylation. J. Biol. Chem. 277 (2002) 33501-33508
26. Wang X.J., Michael D., de Murcia G., and Oren M. p53 activation by nitric oxide involves down-regulation of Mdm2. J. Biol. Chem. 277 (2002) 15697-15702
27. Roy B., Guittet O., Beuneu C., Lemaire G., and Lepoivre M. Depletion of deoxyribonucleoside triphosphate pools in tumor cells by nitric oxide. Free Radic. Biol. Med. 36 (2004) 507-516
28. Brummelkamp T.R., Bernards R., and Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 296 (2002) 550-553
29. Baker S.J., Markowitz S., Fearon E.R., Willson J.K., and Vogelstein B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249 (1990) 912-915
30. Stiewe T., Stanelle J., Theseling C.C., Pollmeier B., Beitzinger M., and Pützer B.M. Inactivation of retinoblastoma (RB) tumor suppressor by oncogenic isoforms of the p53 family member p73. J. Biol. Chem. 278 (2003) 14230-14236
31. Bacus S.S., Yarden Y., Oren M., Chin D.M., Lyass L., Zelnick C.R., Kazarov A., Toyofuku W., Gray-Bablin J., Beerli R.R., Hynes N.E., Nikiforov M., Haffner R., Gudkov A., and Keyomarsi K. Neu differentiation factor (Heregulin) activates a p53-dependent pathway in cancer cells. Oncogene 12 (1996) 2535-2547
32. Håkansson P., Hofer A., and Thelander L. Regulation of mammalian ribonucleotide reduction and dNTP pools after DNA damage and in resting cells. J. Biol. Chem. 281 (2006) 7834-7841
33. Olive P.L., and Banath J.P. The comet assay: a method to measure DNA damage in individual cells. Nat. Protoc. 1 (2006) 23-29
34. Hemish J., Nakaya N., Mittal V., and Enikolopov G. Nitric oxide activates diverse signaling pathways to regulate gene expression. J. Biol. Chem. 278 (2003) 42321-42329
35. Liu X.Y., Zhou B.S., Xue L.J., Shih J., Tye K., Qi C., and Yen Y. The ribonucleotide reductase subunit M2B subcellular localization and functional importance for DNA replication in physiological growth of KB cells. Biochem. Pharmacol. 70 (2005) 1288-1297
36. Grob T.J., Novak U., Maisse C., Barcaroli D., Luthi A.U., Pirnia F., Hugli B., Graber H.U., De Laurenzi V., Fey M.F., Melino G., and Tobler A. Human delta Np73 regulates a dominant negative feedback loop for TAp73 and p53. Cell Death Differ. 8 (2001) 1213-1223